GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » Market Cap

Fresenius Medical Care AG (Fresenius Medical Care AG) Market Cap

: $11,443 Mil (As of Today)
View and export this data going back to 1996. Start your Free Trial

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Fresenius Medical Care AG's share price for the quarter that ended in Dec. 2023 was $20.83. Fresenius Medical Care AG's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 587 Mil. Therefore, Fresenius Medical Care AG's market cap for the quarter that ended in Dec. 2023 was $12,224 Mil.

Fresenius Medical Care AG's quarterly market cap declined from Jun. 2023 ($14,043 Mil) to Sep. 2023 ($12,640 Mil) and declined from Sep. 2023 ($12,640 Mil) to Dec. 2023 ($12,224 Mil).

Fresenius Medical Care AG's annual market cap declined from Dec. 2021 ($19,022 Mil) to Dec. 2022 ($9,589 Mil) but then increased from Dec. 2022 ($9,589 Mil) to Dec. 2023 ($12,224 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Fresenius Medical Care AG's Enterprise Value for Today is $23,916 Mil.


Fresenius Medical Care AG Market Cap Historical Data

The historical data trend for Fresenius Medical Care AG's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21,974.95 24,343.89 19,021.85 9,588.75 12,223.61

Fresenius Medical Care AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,588.75 12,475.94 14,042.77 12,640.25 12,223.61

Competitive Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Market Cap Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Market Cap distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Market Cap falls into.



Fresenius Medical Care AG Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Fresenius Medical Care AG's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=$20.83*586.827
=$12,224

Fresenius Medical Care AG's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=$20.83*586.827
=$12,224

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius Medical Care AG  (NYSE:FMS) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Fresenius Medical Care AG Market Cap Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Executives
Helen Pring Giza Board of Directors